StockData
Grace Therapeutics, Inc. logo

Grace Therapeutics, Inc. (GRCE) stock

GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.72−0.03 (-1.71%)

Close on Nov 17, 2026Market cap $36.18MP/E –Yield –

Grace Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Grace Therapeutics's price to sales ratio was 0.4× on Jul 29, 2022.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jul 29, 20220.4×−278.0
2021Jul 30, 2021278.4×–

More Grace Therapeutics figures

See a number that looks wrong?